Fig. (8).
Results of the meta-analysis of the evaluation of weight gain on treatment with risperidone: (A) short-term (until up 8 weeks); (B) long-term (after 8 weeks); (C) versus placebo in short-term (until up 8 weeks); (D) versus placebo in long-term (after 8 weeks). Confidence Interval (CI), Heterogeneity (I2) and heterogeneity’s p-value (p).